About the TLC conference

TLC 2026

Advancing Precision. Enhancing Collaboration. Improving Outcomes. 

The 4th Annual Texas Lung Cancer Conference (TLC 2026) will convene over 100 leading national experts, rising faculty, and community oncologists for two days of CE-accredited, case-driven education in the heart of Austin. Designed for practicing physicians and multidisciplinary oncology professionals, the conference addresses the most pressing challenges and advances in lung cancer diagnosis, treatment, and patient-centered care. 

Program Highlights: 

• Advanced NSCLC – Targeted Therapy Deep-Dives: EGFR (including exon 20), ALK, ROS1, NTRK/RET/NRG1, BRAF, MET, KRAS G12C, HER2 — with concise evidence updates followed by extended panel discussions featuring both academic and community experts. 

• Immunotherapy in NSCLC: Long-term outcomes with chemo-immunotherapy, dual checkpoint inhibition, patient selection, and toxicity management — with a focus on integrating lessons learned into daily clinical decision-making. 

• Small Cell Lung Cancer (SCLC): Evolving approaches in limited stage and extensive stage disease, relapse strategies, neuroendocrine tumors, and novel agents in the pipeline. 

• Rare Thoracic Tumors: Mesothelioma, thymic cancers, and other uncommon malignancies —highlighting trial updates and treatment innovations. 

• Emerging Therapeutic Modalities: Incorporating bispecific antibodies, antibody–drug conjugates (TROP2, HER2, VEGF/PD-1), tumor treating fields, and cell therapy into standards of care. 

• Precision Diagnostics: NGS, liquid biopsy, minimal residual disease (MRD) assessment, and lung cancer screening — with emphasis on practical adoption barriers and solutions. 

• Early-Stage & Locally Advanced NSCLC: Targeted therapy, immunotherapy, surgical considerations, and multidisciplinary case-based discussions to optimize curative-intent care. 

• Tools for Tomorrow’s Oncologist: AI in thoracic oncology, statistical literacy for clinicians, patient advocacy, and health policy updates that shape oncology practice. 

• Engaging Formats: Rapid-fire updates, interactive panels, structured debates, and non-CE breakfast/lunch symposia for deeper dives into key topics. 
  
  

Every session is designed for practical take-home application — equipping participants with updated evidence, strategic frameworks, and real-world insights to improve patient outcomes. With robust faculty–audience interaction, curated networking opportunities, and a dynamic Austin setting, TLC 2026 offers an unmatched opportunity to engage with leaders shaping thoracic oncology today and tomorrow.